全文获取类型
收费全文 | 159246篇 |
免费 | 10808篇 |
国内免费 | 721篇 |
专业分类
耳鼻咽喉 | 1771篇 |
儿科学 | 3938篇 |
妇产科学 | 2616篇 |
基础医学 | 20975篇 |
口腔科学 | 3408篇 |
临床医学 | 15655篇 |
内科学 | 33757篇 |
皮肤病学 | 3248篇 |
神经病学 | 14613篇 |
特种医学 | 7072篇 |
外国民族医学 | 14篇 |
外科学 | 25237篇 |
综合类 | 1992篇 |
一般理论 | 109篇 |
预防医学 | 11827篇 |
眼科学 | 3310篇 |
药学 | 10212篇 |
中国医学 | 238篇 |
肿瘤学 | 10783篇 |
出版年
2023年 | 888篇 |
2022年 | 1486篇 |
2021年 | 3380篇 |
2020年 | 2081篇 |
2019年 | 3123篇 |
2018年 | 3594篇 |
2017年 | 2802篇 |
2016年 | 3141篇 |
2015年 | 3588篇 |
2014年 | 5098篇 |
2013年 | 6866篇 |
2012年 | 10341篇 |
2011年 | 11008篇 |
2010年 | 6332篇 |
2009年 | 6037篇 |
2008年 | 9755篇 |
2007年 | 10244篇 |
2006年 | 10107篇 |
2005年 | 10164篇 |
2004年 | 9311篇 |
2003年 | 8623篇 |
2002年 | 8273篇 |
2001年 | 2164篇 |
2000年 | 1846篇 |
1999年 | 2135篇 |
1998年 | 1966篇 |
1997年 | 1589篇 |
1996年 | 1362篇 |
1995年 | 1280篇 |
1994年 | 1152篇 |
1993年 | 1053篇 |
1992年 | 1297篇 |
1991年 | 1196篇 |
1990年 | 1043篇 |
1989年 | 997篇 |
1988年 | 935篇 |
1987年 | 899篇 |
1986年 | 899篇 |
1985年 | 879篇 |
1984年 | 933篇 |
1983年 | 798篇 |
1982年 | 967篇 |
1981年 | 864篇 |
1980年 | 738篇 |
1979年 | 656篇 |
1978年 | 649篇 |
1977年 | 540篇 |
1976年 | 515篇 |
1974年 | 511篇 |
1973年 | 449篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
111.
112.
113.
Seventy-four patients with impaired renal function were investigated by ultrasound. By assessing renal length, renal echogenicity and collecting system dilatation, one can establish whether renal function is impaired by chronic or acute renal changes or by obstructive changes. 相似文献
114.
M J Thomas 《Indian pediatrics》1987,24(5):441-443
115.
116.
David G Hicks Brian J Yoder Sarah Short Shannon Tarr Nichole Prescott Joseph P Crowe Andrea E Dawson G Thomas Budd Steven Sizemore Muzaffer Cicek Toni K Choueiri Raymond R Tubbs Daniel Gaile Norma Nowak Mary Ann Accavitti-Loper Andra R Frost Danny R Welch Graham Casey 《Clinical cancer research》2006,12(22):6702-6708
PURPOSE: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen receptor (ER), progesterone receptor (PR), or HER2 status, and to determine whether loss of BRMS1 protein expression correlated with genomic copy number changes. EXPERIMENTAL DESIGN: A tissue microarray immunohistochemical analysis was done on tumors of 238 newly diagnosed breast cancer patients who underwent surgery at the Cleveland Clinic between January 1, 1995 and December 31, 1996, and a comparison was made with 5-year clinical follow-up data. Genomic copy number changes were determined by array-based comparative genomic hybridization in 47 breast cancer cases from this population and compared with BRMS1 staining. RESULTS: BRMS1 protein expression was lost in nearly 25% of cases. Patients with tumors that were PR negative (P=0.006) or HER2 positive (P=0.039) and <50 years old at diagnosis (P=0.02) were more likely to be BRMS1 negative. No overall correlation between BRMS1 staining and disease-free survival was observed. A significant correlation, however, was seen between loss of BRMS1 protein expression and reduced disease-free survival when stratified by either loss of ER (P=0.008) or PR (P=0.029) or HER2 overexpression (P=0.026). Overall, there was poor correlation between BRMS1 protein staining and copy number status. CONCLUSIONS: These data suggest a mechanistic relationship between BRMS1 expression, hormone receptor status, and HER2 growth factor. BRMS1 staining could potentially be used in patient stratification in conjunction with other prognostic markers. Further, mechanisms other than genomic deletion account for loss of BRMS1 gene expression in breast tumors. 相似文献
117.
118.
Holger F. Boehm Felix Eckstein Caecilia Wunderer Volker Kuhn Eva-Maria Lochmueller Karin Schreiber Dirk Mueller Ernst J. Rummeny Thomas M. Link 《Journal of clinical densitometry》2005,8(4):488-494
We tested the hypothesis that bone mineral density (BMD) and bone mineral content (BMC) in proximal human femur specimens in the upper neck region of interest (ROI) and femoral neck axis length (FNAL) provide a significantly better prediction of femoral bone strength than standard ROIs in vitro. BMD and BMC were measured in 110 proximal femur specimens using a standard dual-energy X-ray absorptiometry (DXA) scanner. The analysis included a new ROI in the upper neck as well as the standard ROIs. FNAL was obtained from the scan images. The specimens' failure-load was measured in a mechanical loading device, simulating a fall on the greater trochanter. For the standard ROIs, correlations between failure-load and BMD ranged from R2 = 0.64 (shaft ROI) to R2 = 0.70, p < 0.001 (femoral neck). Prediction of strength by BMD did not significantly differ from those of BMC (R2 ranging from 0.65 to 0.75, p < 0.001). In the upper neck ROI, for both BMD and BMC correlations with failure-load were higher (R2 = 0.76 and 0.81, respectively; p < 0.001). A lower, yet still significant, correlation was found between FNAL and bone strength (R2 = 0.23, p < 0.001). Normalization of failure-load with respect to FNAL did not significantly increase the correlations with densitometric measures. This study provides in vitro evidence indicating that among the ROIs of the proximal femur the newly defined upper neck ROI provides the best prediction of bone strength. Only a weak association was observed between failure load and FNAL. 相似文献
119.
120.
Raymond Tubbs James Pettay Richard Powell David G Hicks Patrick Roche William Powell Thomas Grogan James F Hainfeld 《Applied immunohistochemistry & molecular morphology》2005,13(4):371-375
Ultrasensitive bright field in situ hybridization assays using enzyme metallography (EnzMet) have been developed and validated, but little is known regarding the applicability of EnzMet for immunophenotypic detection of protein via IHC. Superior resolution via discrete metallographic deposits offers the potential for enhancing high-resolution immunophenotyping. Using high-complexity tissue microarrays (TMAs), 88 common solid tumors were evaluated by automated EnzMet (Nanoprobes and Ventana). Targets were chosen to assess the ability of EnzMet to specifically localize encoded antigens in the nucleus (estrogen receptor), cytoplasm (cytokeratins), and cytoplasmic membrane (HER2) in TMAs. Results were compared with conventional IHC diaminobenzidine (DAB) immunostaining. There was full concordance between the EnzMet and conventional IHC results. Furthermore, the EnzMet reaction products did not appreciably diffuse, were dense and sharply defined, and provided excellent high-resolution differentiation of cellular compartments in paraffin sections for the nuclear, cytoplasmic, and cell membrane-localized antigens evaluated. The higher density of elemental silver deposited during enzyme metallography permitted evaluation of core immunophenotypes at a relatively low magnification, allowing more tissue to be screened in an efficient manner. This preliminary study shows the utility of using enzyme metallography for high-resolution immunophenotyping in TMAs. 相似文献